Silver Book Fact

In the U.S., new cancer drugs have increased life expectancy at birth by 10.7%.

The Expanding Pharmaceutical Arsenal in the War on Cancer. Working Paper No. 10328 Web site. http://www.nber.org/papers/w10328. Published Feb. 2004

Reference

Title
The Expanding Pharmaceutical Arsenal in the War on Cancer
Publication
Working Paper No. 10328
Publisher
National Bureau of Economic Research
Publication Date
Published Feb. 2004
Authors
Lichtenberg, Frank R
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Since Congress passed the National Cancer Act in 1971, the percentage of the U.S. population living with, through, or beyond a cancer diagnosis has more than tripled.  
  • A one percent reduction in lung, colorectal, breast, leukemia, pancreatic, and brain cancer mortality would reduce productivity costs by $814 million per year.  
  • Reductions in mortality for lung, female breast, prostate, and colorectal cancers accounted for 60 to 80 percent of the total decrease in all cancer deaths since the early 1990s.  
  • Cancer mortality declined more than 2% in 2003, a continuation of the decline that began in 1990.  
  • 750 cancer-fighting medicines are currently in development.